Preview Mode Links will not work in preview mode

This Week in Cardiology

May 31, 2024

The FLOW trial of semaglutide, the DANCAVAS CV screening trial, non-invasive tests for chest pain, and conflicts of interest on social media are the topics John Mandrola, MD, discusses this week.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

I. Semaglutide for CKD

Semaglutide Significantly Improves Chronic Kidney Disease

  • FLOW Trial

II. CV Screening

Judicious CVD Screening May Work in Men: DANCAVAS

  • DANCAVAS 6-Year Outcomes
  • DANCAVAS Main Trial NEJM

III. Non-invasive Cardiac Testing in Chest Pain

  • Circulation Outcomes Paper
  • Scot Heart

IV. COI and Social Media

  • JAMA letter

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact